Skip to content

Comparison Between 3-L and 4-L Polyethylene Glycol in Bowel Preparation

Comparison of the Efficacy and Tolerability Between 3-L and 4-L Polyethylene Glycol in Bowel Preparation

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03356015
Enrollment
260
Registered
2017-11-29
Start date
2017-12-01
Completion date
2018-02-01
Last updated
2017-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adenoma Detection Rate, Bowel Preparation Scale

Keywords

Polyp detection rate, Adenoma detection rate, Boston Bowel Preparation Scale

Brief summary

High quality bowel preparation is essential for successful colonoscopy. This study aimed to assess the impact of the dose of Polyethylene Glycol(PEG) on the quality of bowel preparation. This prospective, endoscopist-blinded, randomized, controlled study was conducted. 3L-group received 3 bags of PEG and were instructed to drink 1L at 19:00 in the evening before the day of colonoscopy at a rate of 250 mL every 15 minutes, and to drink the remaining 2L 4 to 6 h before colonoscopy at the same rate. 4L-group received 4bags of PEG and were instructed to drink 2 L at 19:00 in the evening before the day of colonoscopy at a rate of 250 mL every 15 minutes, and to drink the remaining 2L 4 to 6 h before colonoscopy at the same rate. The primary outcome was the quality of the bowel preparation according to the Boston Bowel Preparation Scale (BBPS). The secondary outcomes included polyp detection rate (PDR), adenoma detection rate (ADR), tolerance, and subjective feelings of patients.

Interventions

DRUG4L Polyethylene Glycol

4L group received double-dose PEG at 19:00 in the evening before the day of colonoscopy at a rate of 250 mL every 15 minutes.

DRUG3L Polyethylene Glycol

3L group were instructed to drink 1L PEG at 19:00 in the evening before the day of colonoscopy at a rate of 250 mL every 15 minutes

Sponsors

Changhai Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

1. Outpatients aged 18-75 years 2. Referred for routine diagnostic colonoscopy 3. Patients who have signed inform consent form

Exclusion criteria

1. pregnancy or breastfeeding 2. allergy to purgatives 3. suspected intestinal obstruction, stricture, or perforation 4. hemodynamic instability 5. impaired swallowing reflex or mental status 6. severely medical status, such as New York Heart Association grade III or grade IV congestive heart failure and severe renal failure 7. history of oesophagus、stomach 、duodenum、small intestine or colorectal surgery 8. participation declined.

Design outcomes

Primary

MeasureTime frameDescription
the Boston Bowel Preparation Scale2 daysThe primary end point of the study was adequate bowel preparation quality de ned as a BBPS total score of ≥6 with all segment scores ≥2

Secondary

MeasureTime frameDescription
Polyp detection rate2 daysThe secondary end point of the study included polyp detection rate
Adenoma detection rate2 daysThe secondary end point of the study included adenoma detection rate
The mean number of incremental adenomas2 daysIt was a new metric called ADR-Plus, the mean number of incremental adenomas after the fist.

Countries

China

Contacts

Primary ContactZhaosheng Li, MD
zhaoshenlismmu@gmail.com+86-21-25070552
Backup ContactYu Bai, MD
baiyu1998@hotmail.com+86-13564665324

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026